Search Within

Ping Chi

  1. "MSK Grad Students"
Formats
  1. Journal Article (25)
  2. Meeting Abstract (14)
Groups
  1. Department of Medicine (39)
  2. GSK Faculty (39)
  3. Human Oncology and Pathogenesis Program (39)
  4. MSK Grad Students (39)
  5. Sarcoma Service (39)
  6. Solid Tumor Oncology Division (39)

More Groups

People
  1. Yu Chen (27)
  2. Cristina Antonescu (21)
  3. Leili Ran (15)
  4. Samuel Singer (14)
  5. Wai Pung Wong (13)
  6. William Tap (13)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (2)
  4. 2022 (13)
  5. 2021 (3)
  6. 2020 (2)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Cancer Research (8)
  3. Cancer Discovery (3)
  4. Annals of Oncology (2)
  5. Cell (2)
  6. Journal of Clinical Investigation (2)

More Publications

Publishers
  1. American Association for Cancer Research (20)
  2. Nature Publishing Group (5)
  3. Cell Press (4)
  4. American Society for Clinical Investigation (2)
  5. American Society of Clinical Oncology (2)
  6. Oxford University Press (2)

More Publishers

Results (39)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of KMT2C or KMT2D primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters
    Journal Article

    Wang, N.; Pachai, M. R.; Li, D.; Lee, C. J.; Warda, S.; Khudoynazarova, M. N.; Cho, W. H.; Xie, G.; Shah, S. R.; Yao, L.; more...
    Nature Genetics (2025)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • MEK inhibitors lead to PDGFR pathway upregulation and sensitize tumors to RAF dimer inhibitors in NF1-deficient malignant peripheral nerve sheath tumor
    Journal Article

    Miranda-Román, M. A.; Lee, C. J.; Fishinevich, E.; Ran, L.; Patel, A. J.; Yan, J.; Khudoynazarova, M. N.; Warda, S.; Pachai, M. R.; Chen, Y.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Histology-specific prognostication for radiation-associated soft tissue sarcoma
    Journal Article

    Bartlett, E. K.; Sharma, A.; Seier, K.; Antonescu, C. R.; Agaram, N. P.; Jadeja, B.; Rosenbaum, E.; Chi, P.; Brennan, M. F.; Qin, L. X.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment
    Meeting Abstract

    Yan, J.; Chen, Y.; Patel, A. J.; Lee, C. J.; Warda, S.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Inactivation mutations of KMT2C/D license a molecular "field effect" and prime the urothelium for tumorigenesis
    Meeting Abstract

    Wang, N.; Pachai, M. R.; Li, D.; Lee, C.; Warda, S.; Xie, G.; Qian, C.; Wong, W. P. E.; Yan, J.; Hu, W.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
    Meeting Abstract

    Tang, F.; Xu, D.; Wang, S.; Wong, C. K.; Martinez-Fundichely, A.; Lee, C.; Cohen, S.; Park, J.; Hill, C.; Eng, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save